. | NGT . | IFG/IGT . | Type 2 diabetes† . | |||
---|---|---|---|---|---|---|
Male . | Female . | Male . | Female . | Male . | Female . | |
Metablic syndrome | ||||||
all 35–70 years | 15 | 10 | 64 | 42 | 84 | 78 |
40–49 years | 12 | 6 | 59 | 38 | 87 | 78 |
50–59 years | 20 | 9 | 67 | 44 | 83 | 74 |
60–69 years | 20‡ | 19∥ | 66 | 52‡ | 84 | 81 |
Obesity | ||||||
all 35–70 years | 76 | 36 | 86 | 51 | 92 | 78 |
40–49 years | 76 | 34 | 87 | 49 | 95 | 80 |
50–59 years | 81 | 32 | 86 | 56 | 93 | 79 |
60–69 years | 80 | 44‡ | 89 | 53 | 92 | 78 |
Dyslipidemia | ||||||
all 35–70 years | 29 | 16 | 45 | 31 | 54 | 56 |
40–49 years | 31 | 13 | 51 | 25 | 66 | 64 |
50–59 years | 28 | 17 | 46 | 31 | 55 | 51 |
60–69 years | 23 | 21‡ | 39 | 37‡ | 50§ | 57 |
Hypertension | ||||||
all 35–70 years | 23 | 24 | 31 | 35 | 55 | 59 |
40–49 years | 20 | 17 | 19 | 31 | 42 | 47 |
50–59 years | 27 | 29 | 41 | 34 | 55 | 53 |
60–69 years | 35∥ | 41∥ | 39§ | 47‡ | 59§ | 67∥ |
Microalbuminuria | ||||||
all 35–70 years | 4 | 3 | 7 | 6 | 22 | 12 |
40–49 years | 3 | 4 | 1 | 6 | 14 | 18 |
50–59 years | 3 | 2 | 8 | 8 | 19 | 12 |
60–69 years | 8 | 1 | 9‡ | 9 | 26 | 11 |
Insulin resistance¶ | ||||||
all 35–70 years | 25 | 25 | 58 | 59 | 87 | 89 |
40–49 years | 23 | 19 | 53 | 52 | 87 | 89 |
50–59 years | 28 | 24 | 65 | 57 | 87 | 89 |
60–69 years | 29 | 35∥ | 59 | 68‡ | 86 | 90 |
. | NGT . | IFG/IGT . | Type 2 diabetes† . | |||
---|---|---|---|---|---|---|
Male . | Female . | Male . | Female . | Male . | Female . | |
Metablic syndrome | ||||||
all 35–70 years | 15 | 10 | 64 | 42 | 84 | 78 |
40–49 years | 12 | 6 | 59 | 38 | 87 | 78 |
50–59 years | 20 | 9 | 67 | 44 | 83 | 74 |
60–69 years | 20‡ | 19∥ | 66 | 52‡ | 84 | 81 |
Obesity | ||||||
all 35–70 years | 76 | 36 | 86 | 51 | 92 | 78 |
40–49 years | 76 | 34 | 87 | 49 | 95 | 80 |
50–59 years | 81 | 32 | 86 | 56 | 93 | 79 |
60–69 years | 80 | 44‡ | 89 | 53 | 92 | 78 |
Dyslipidemia | ||||||
all 35–70 years | 29 | 16 | 45 | 31 | 54 | 56 |
40–49 years | 31 | 13 | 51 | 25 | 66 | 64 |
50–59 years | 28 | 17 | 46 | 31 | 55 | 51 |
60–69 years | 23 | 21‡ | 39 | 37‡ | 50§ | 57 |
Hypertension | ||||||
all 35–70 years | 23 | 24 | 31 | 35 | 55 | 59 |
40–49 years | 20 | 17 | 19 | 31 | 42 | 47 |
50–59 years | 27 | 29 | 41 | 34 | 55 | 53 |
60–69 years | 35∥ | 41∥ | 39§ | 47‡ | 59§ | 67∥ |
Microalbuminuria | ||||||
all 35–70 years | 4 | 3 | 7 | 6 | 22 | 12 |
40–49 years | 3 | 4 | 1 | 6 | 14 | 18 |
50–59 years | 3 | 2 | 8 | 8 | 19 | 12 |
60–69 years | 8 | 1 | 9‡ | 9 | 26 | 11 |
Insulin resistance¶ | ||||||
all 35–70 years | 25 | 25 | 58 | 59 | 87 | 89 |
40–49 years | 23 | 19 | 53 | 52 | 87 | 89 |
50–59 years | 28 | 24 | 65 | 57 | 87 | 89 |
60–69 years | 29 | 35∥ | 59 | 68‡ | 86 | 90 |
Data are %.
The definition of the metabolic syndrome was based on the recent WHO proposal (17);
P < 0.001 for differences in all variables between subjects with diabetes and NGT/IFG/IGT when men and women aged 35–70 years were compared separately;
P < 0.05;
P < 0.01;
P < 0.001 when age decade 60–69 was compared to age decade 40–49;
highest quartile of HOMAIR.